サンプルお申込み

お問い合わせ

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は神経学的治療市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは神経学的治療の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の神経学的治療市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは神経学的治療のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に神経学的治療市場を分類しています。本研究に含まれる主な企業は：Abbott Laboratories、Accuray Incorporated、Boston Scientific、CR Bard、Eli Lilly、Janssen Biotech、Pfizer、Siemens、Varian Medical Systems、Ultragenyx Pharmaceutical

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Plantar Fasciitis
    Ankylosing Spondylitis
    Spondyloarthropathy
    Rotator-Cuff Syndrome
    Achilles Tendonitis
    Others

用途別の市場セグメント：
    Children
    Adult

本レポートの詳細内容
世界の神経学的治療市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、神経学的治療タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の神経学的治療収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の神経学的治療市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、神経学的治療市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

神経学的治療のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：神経学的治療のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：神経学的治療の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章神経学的治療企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：神経学的治療の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：神経学的治療の主要企業の概要を提供し、製品の説明と仕様、神経学的治療の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Enthesopathy is derived from a combination of entheso means a specific structure within the musculoskeletal system and pathy means presence of pathology.

Market Analysis and Insights: Global Enthesopathy Treatment Market
The global Enthesopathy Treatment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Enthesopathy Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Enthesopathy Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Enthesopathy Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Enthesopathy Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Enthesopathy Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Enthesopathy Treatment revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott Laboratories, Accuray Incorporated, Boston Scientific, CR Bard, Eli Lilly, Janssen Biotech, Pfizer, Siemens and Varian Medical Systems, etc.

Market Segmentation
By Company
    Abbott Laboratories
    Accuray Incorporated
    Boston Scientific
    CR Bard
    Eli Lilly
    Janssen Biotech
    Pfizer
    Siemens
    Varian Medical Systems
    Ultragenyx Pharmaceutical

Segment by Type
    Plantar Fasciitis
    Ankylosing Spondylitis
    Spondyloarthropathy
    Rotator-Cuff Syndrome
    Achilles Tendonitis
    Others

Segment by Application
    Children
    Adult

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Enthesopathy Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Enthesopathy Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Enthesopathy Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Enthesopathy Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Plantar Fasciitis
    Table 3. Key Players of Ankylosing Spondylitis
    Table 4. Key Players of Spondyloarthropathy
    Table 5. Key Players of Rotator-Cuff Syndrome
    Table 6. Key Players of Achilles Tendonitis
    Table 7. Key Players of Others
    Table 8. Global Enthesopathy Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 9. Global Enthesopathy Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 10. Global Enthesopathy Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 11. Global Enthesopathy Treatment Market Share by Region (2019-2024)
    Table 12. Global Enthesopathy Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 13. Global Enthesopathy Treatment Market Share by Region (2025-2030)
    Table 14. Enthesopathy Treatment Market Trends
    Table 15. Enthesopathy Treatment Market Drivers
    Table 16. Enthesopathy Treatment Market Challenges
    Table 17. Enthesopathy Treatment Market Restraints
    Table 18. Global Enthesopathy Treatment Revenue by Players (2019-2024) & (US$ Million)
    Table 19. Global Enthesopathy Treatment Revenue Share by Players (2019-2024)
    Table 20. Global Top Enthesopathy Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enthesopathy Treatment as of 2023)
    Table 21. Global Enthesopathy Treatment Industry Ranking 2022 VS 2023 VS 2024
    Table 22. Global 5 Largest Players Market Share by Enthesopathy Treatment Revenue (CR5 and HHI) & (2019-2024)
    Table 23. Global Key Players of Enthesopathy Treatment, Headquarters and Area Served
    Table 24. Global Key Players of Enthesopathy Treatment, Product and Application
    Table 25. Global Key Players of Enthesopathy Treatment, Product and Application
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Enthesopathy Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 28. Global Enthesopathy Treatment Revenue Market Share by Type (2019-2024)
    Table 29. Global Enthesopathy Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 30. Global Enthesopathy Treatment Revenue Market Share by Type (2025-2030)
    Table 31. Global Enthesopathy Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 32. Global Enthesopathy Treatment Revenue Share by Application (2019-2024)
    Table 33. Global Enthesopathy Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 34. Global Enthesopathy Treatment Revenue Share by Application (2025-2030)
    Table 35. North America Enthesopathy Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 36. North America Enthesopathy Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 37. North America Enthesopathy Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 38. North America Enthesopathy Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 39. North America Enthesopathy Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 40. North America Enthesopathy Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 41. North America Enthesopathy Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 42. Europe Enthesopathy Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 43. Europe Enthesopathy Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 44. Europe Enthesopathy Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 45. Europe Enthesopathy Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 46. Europe Enthesopathy Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 47. Europe Enthesopathy Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 48. Europe Enthesopathy Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 49. China Enthesopathy Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 50. China Enthesopathy Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 51. China Enthesopathy Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 52. China Enthesopathy Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Enthesopathy Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 54. Asia Enthesopathy Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 55. Asia Enthesopathy Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 56. Asia Enthesopathy Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 57. Asia Enthesopathy Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 58. Asia Enthesopathy Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 59. Asia Enthesopathy Treatment Market Size by Region (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Enthesopathy Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Enthesopathy Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Enthesopathy Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Enthesopathy Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Enthesopathy Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 65. Middle East, Africa, and Latin America Enthesopathy Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 66. Middle East, Africa, and Latin America Enthesopathy Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 67. Abbott Laboratories Company Details
    Table 68. Abbott Laboratories Business Overview
    Table 69. Abbott Laboratories Enthesopathy Treatment Product
    Table 70. Abbott Laboratories Revenue in Enthesopathy Treatment Business (2019-2024) & (US$ Million)
    Table 71. Abbott Laboratories Recent Developments
    Table 72. Accuray Incorporated Company Details
    Table 73. Accuray Incorporated Business Overview
    Table 74. Accuray Incorporated Enthesopathy Treatment Product
    Table 75. Accuray Incorporated Revenue in Enthesopathy Treatment Business (2019-2024) & (US$ Million)
    Table 76. Accuray Incorporated Recent Developments
    Table 77. Boston Scientific Company Details
    Table 78. Boston Scientific Business Overview
    Table 79. Boston Scientific Enthesopathy Treatment Product
    Table 80. Boston Scientific Revenue in Enthesopathy Treatment Business (2019-2024) & (US$ Million)
    Table 81. Boston Scientific Recent Developments
    Table 82. CR Bard Company Details
    Table 83. CR Bard Business Overview
    Table 84. CR Bard Enthesopathy Treatment Product
    Table 85. CR Bard Revenue in Enthesopathy Treatment Business (2019-2024) & (US$ Million)
    Table 86. CR Bard Recent Developments
    Table 87. Eli Lilly Company Details
    Table 88. Eli Lilly Business Overview
    Table 89. Eli Lilly Enthesopathy Treatment Product
    Table 90. Eli Lilly Revenue in Enthesopathy Treatment Business (2019-2024) & (US$ Million)
    Table 91. Eli Lilly Recent Developments
    Table 92. Janssen Biotech Company Details
    Table 93. Janssen Biotech Business Overview
    Table 94. Janssen Biotech Enthesopathy Treatment Product
    Table 95. Janssen Biotech Revenue in Enthesopathy Treatment Business (2019-2024) & (US$ Million)
    Table 96. Janssen Biotech Recent Developments
    Table 97. Pfizer Company Details
    Table 98. Pfizer Business Overview
    Table 99. Pfizer Enthesopathy Treatment Product
    Table 100. Pfizer Revenue in Enthesopathy Treatment Business (2019-2024) & (US$ Million)
    Table 101. Pfizer Recent Developments
    Table 102. Siemens Company Details
    Table 103. Siemens Business Overview
    Table 104. Siemens Enthesopathy Treatment Product
    Table 105. Siemens Revenue in Enthesopathy Treatment Business (2019-2024) & (US$ Million)
    Table 106. Siemens Recent Developments
    Table 107. Varian Medical Systems Company Details
    Table 108. Varian Medical Systems Business Overview
    Table 109. Varian Medical Systems Enthesopathy Treatment Product
    Table 110. Varian Medical Systems Revenue in Enthesopathy Treatment Business (2019-2024) & (US$ Million)
    Table 111. Varian Medical Systems Recent Developments
    Table 112. Ultragenyx Pharmaceutical Company Details
    Table 113. Ultragenyx Pharmaceutical Business Overview
    Table 114. Ultragenyx Pharmaceutical Enthesopathy Treatment Product
    Table 115. Ultragenyx Pharmaceutical Revenue in Enthesopathy Treatment Business (2019-2024) & (US$ Million)
    Table 116. Ultragenyx Pharmaceutical Recent Developments
    Table 117. Research Programs/Design for This Report
    Table 118. Key Data Information from Secondary Sources
    Table 119. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Enthesopathy Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Enthesopathy Treatment Market Share by Type: 2023 VS 2030
    Figure 3. Plantar Fasciitis Features
    Figure 4. Ankylosing Spondylitis Features
    Figure 5. Spondyloarthropathy Features
    Figure 6. Rotator-Cuff Syndrome Features
    Figure 7. Achilles Tendonitis Features
    Figure 8. Others Features
    Figure 9. Global Enthesopathy Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 10. Global Enthesopathy Treatment Market Share by Application: 2023 VS 2030
    Figure 11. Children Case Studies
    Figure 12. Adult Case Studies
    Figure 13. Enthesopathy Treatment Report Years Considered
    Figure 14. Global Enthesopathy Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Enthesopathy Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Enthesopathy Treatment Market Share by Region: 2023 VS 2030
    Figure 17. Global Enthesopathy Treatment Market Share by Players in 2023
    Figure 18. Global Top Enthesopathy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enthesopathy Treatment as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Enthesopathy Treatment Revenue in 2023
    Figure 20. North America Enthesopathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Enthesopathy Treatment Market Share by Type (2019-2030)
    Figure 22. North America Enthesopathy Treatment Market Share by Application (2019-2030)
    Figure 23. North America Enthesopathy Treatment Market Share by Country (2019-2030)
    Figure 24. United States Enthesopathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada Enthesopathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Enthesopathy Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 27. Europe Enthesopathy Treatment Market Share by Type (2019-2030)
    Figure 28. Europe Enthesopathy Treatment Market Share by Application (2019-2030)
    Figure 29. Europe Enthesopathy Treatment Market Share by Country (2019-2030)
    Figure 30. Germany Enthesopathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. France Enthesopathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. U.K. Enthesopathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Italy Enthesopathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Russia Enthesopathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Nordic Countries Enthesopathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. China Enthesopathy Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. China Enthesopathy Treatment Market Share by Type (2019-2030)
    Figure 38. China Enthesopathy Treatment Market Share by Application (2019-2030)
    Figure 39. Asia Enthesopathy Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. Asia Enthesopathy Treatment Market Share by Type (2019-2030)
    Figure 41. Asia Enthesopathy Treatment Market Share by Application (2019-2030)
    Figure 42. Asia Enthesopathy Treatment Market Share by Region (2019-2030)
    Figure 43. Japan Enthesopathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. South Korea Enthesopathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. China Taiwan Enthesopathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Enthesopathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. India Enthesopathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Australia Enthesopathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Enthesopathy Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Enthesopathy Treatment Market Share by Type (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Enthesopathy Treatment Market Share by Application (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Enthesopathy Treatment Market Share by Country (2019-2030)
    Figure 53. Brazil Enthesopathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Mexico Enthesopathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Turkey Enthesopathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Saudi Arabia Enthesopathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Israel Enthesopathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. GCC Countries Enthesopathy Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Abbott Laboratories Revenue Growth Rate in Enthesopathy Treatment Business (2019-2024)
    Figure 60. Accuray Incorporated Revenue Growth Rate in Enthesopathy Treatment Business (2019-2024)
    Figure 61. Boston Scientific Revenue Growth Rate in Enthesopathy Treatment Business (2019-2024)
    Figure 62. CR Bard Revenue Growth Rate in Enthesopathy Treatment Business (2019-2024)
    Figure 63. Eli Lilly Revenue Growth Rate in Enthesopathy Treatment Business (2019-2024)
    Figure 64. Janssen Biotech Revenue Growth Rate in Enthesopathy Treatment Business (2019-2024)
    Figure 65. Pfizer Revenue Growth Rate in Enthesopathy Treatment Business (2019-2024)
    Figure 66. Siemens Revenue Growth Rate in Enthesopathy Treatment Business (2019-2024)
    Figure 67. Varian Medical Systems Revenue Growth Rate in Enthesopathy Treatment Business (2019-2024)
    Figure 68. Ultragenyx Pharmaceutical Revenue Growth Rate in Enthesopathy Treatment Business (2019-2024)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed